Stayble Therapeutics AB (publ) (STO:STABL)

Stayble Therapeutics AB Revenue

Stayble Therapeutics AB had revenue of 1,000.00 SEK in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to -340.00K, down -190.43% year-over-year.

• Revenue (ttm): -340.00K
• Revenue Growth: -190.43%
• P/S Ratio: -33.54
• Revenue / Employee: -170.00K
• Employees: 2
• Market Cap: 11.40M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-